IDEAYA Announces IDE397 Clinical Program Update and ctDNA Molecular Responses Demonstrating Tumor Pharmacodynamic Modulation
Initiated monotherapy expansion cohorts with enrollment open for NSCLC and esophagogastric tumors with MTAP deletion Initiated combination dose escalation...
Yujiros Hata Michael White Biosciences Inc Clinical Trial Collaboration Supply Agreement Option Data Package
Source: prnewswire.com